Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3aapFPJ
via IFTTT